TRIGR Therapeutics, Inc. Press releases
Dec 23, 2018
TRIGR Therapeutics, Inc. ("TRIGR"), a privately held biotechnology company focused on the clinical development and commercialization of bispecific antibody therapeutics for oncology and ophthalmology indications, announced that it will present at Biotech.